Polyrizon (NASDAQ:PLRZ) Stock Price Up 1.7% – What’s Next?

Polyrizon Ltd. (NASDAQ:PLRZ)’s stock price was up 1.7% during trading on Tuesday . The stock traded as high as $13.92 and last traded at $13.49. Approximately 18,732 shares were traded during mid-day trading, a decline of 48% from the average session volume of 35,779 shares. The stock had previously closed at $13.26.

Wall Street Analyst Weigh In

PLRZ has been the topic of several recent analyst reports. Wall Street Zen raised shares of Polyrizon from a “sell” rating to a “hold” rating in a research report on Sunday, June 7th. Weiss Ratings raised Polyrizon from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, July 13th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Polyrizon has an average rating of “Sell”.

Polyrizon Stock Performance

The business has a 50-day moving average price of $13.56 and a 200 day moving average price of $13.56.

Institutional Investors Weigh In On Polyrizon

A hedge fund recently bought a new position in Polyrizon stock. Jane Street Group LLC bought a new position in shares of Polyrizon Ltd. (NASDAQ:PLRZ) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned 1.35% of Polyrizon as of its most recent SEC filing.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.